Tower Research Capital LLC (Trc) Harvard Bioscience Inc Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 8,462 shares of HBIO stock, worth $5,500. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,462
Previous 15,618
45.82%
Holding current value
$5,500
Previous $6,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding HBIO
# of Institutions
65Shares Held
19.5MCall Options Held
54KPut Options Held
0-
Amh Equity LTD4.05MShares$2.63 Million2.46% of portfolio
-
Black Rock Inc. New York, NY2.84MShares$1.85 Million0.0% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.05MShares$1.33 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.85MShares$1.2 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.07MShares$695,2980.0% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $27.1M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...